Decontamination system with improved components

Chemical apparatus and process disinfecting – deodorizing – preser – Chemical reactor – With means applying electromagnetic wave energy or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

422 20, 422 22, 422 24, 422127, 422128, 422186, 4221863, 422900, 422907, C02F 130, C02F 132, C02F 136, C02F 148

Patent

active

059650931

DESCRIPTION:

BRIEF SUMMARY
BACKGROUND OF THE INVENTION

Since the 19th Century discovery of the cause of cholera epidemics in London and their prevention through treatment of sewage and other effluent to remove and/or kill organisms within the effluent, many advances have been made in the treatment of organically polluted effluent. Early in the development of water treatment systems, chlorine and other halides were found to have deleterious effects on water born organisms, and chlorine compounds are now commonly used to reduce the number of living organisms in water supplies to reasonably safe levels.
It has also been determined that photonic absorption, such as is possible with high levels of radiation at preferentially absorbed frequencies, can cause total photodynamic inactivation of several bacteriophages. (See R. Hall as cited in General Electric Lamp bulletin LD-14; and M. Luckiesh, "Germicidal Eythermal Energy Research" from D. Van Nostrand Co). When a non-fluorescing organism absorbs a photon, the energy is usually converted into vibrational energy (heat) that raises the internal temperature of the organism. Viral organisms are extremely sensitive to such energy. They are so small that the absorption of very few photons causes their internal temperature to rise to levels that are dangerous to their continued existence. In fact, this form of heat energy within viral organisms, causes viral inactivation when the temperatures there within exceed 100.degree. C.
Photobiologists have discovered absorption curves for various biological parts. For example, proteins normally have peak absorption when exposed to radiated ultraviolet (UV) energy at wavelengths of 300 nanometers (nm) to 280 nm, and ribonucleic acid (RNA) has an absorption peak to radiant wavelengths from 265 nm to 245 nm, with an absolute peak at 253.7 nm. The peak absorption for virions occurs at about 260 nm. 184.9 nm energy is the peak energy used for the breakdown of the hydrogen bond that links the DNA chain and phosphorous bond that links the RNA chain. In addition, application of 184.9 nm UV causes free oxygen molecules in the substance under treatment to add an oxygen atom to form ozone, a proven virion deactivator.
Therefore, sterilizers have been constructed that expose a fluid stream to ultraviolet radiation in the 300 nm to 180 nm wavelength range at an applied power of the 30 Kergs per mm.sup.2 or more required to disassociate the deoxyribonucleic acid (DNA) and RNA of viral organisms.
Although with prior art UV sterilization devices, it has been possible to provide UV energy in the correct range of wavelengths and at lethal power levels, such UV devices have had numerous disadvantageous features. First, many have poorly designed flow channels that allow organisms to flow there through without receiving a lethal dose of ultraviolet radiation. Most apply the requisite amount of UV too slowly, thereby allowing viral organisms to produce pigment like molecules that dilute the effect of UV light so that what should be a lethal level, can be withstood. Studies have shown that certain types of viral organisms can produce the UV blocking molecules in as little as ten milliseconds. This means that to apply a lethal dose of UV energy to those virions capable of protecting themselves from UV light, enormous concentrations of UV energy must be provided, since a lethal or at least a debilitating amount of UV energy must be applied and absorbed by every exposed viral organism in less than the first ten milliseconds that the viral organism is exposed. Commercially available intense UV sources used in the prior art devices tend to be narrow frequency devices that are unable to produce lethal intensity at all the peak absorption wavelengths of organisms. The broadband UV energy producing devices that are available produce UV light at relatively low power levels. Examples of these latter sources are UV fluorescent tubes, which produce UV at such low levels that literally hundreds of thousands of lamps are required to treat the effluent in a normal commercial sewage treatmen

REFERENCES:
patent: 2122741 (1938-07-01), Haddad
patent: 3336220 (1967-08-01), Neidi
patent: 3617178 (1971-11-01), Clouston
patent: 3672823 (1972-06-01), Boucher
patent: 3725226 (1973-04-01), Stoner
patent: 3753886 (1973-08-01), Myers
patent: 4013552 (1977-03-01), Kreuter
patent: 4066544 (1978-01-01), Stark
patent: 4123339 (1978-10-01), Gale et al.
patent: 4179616 (1979-12-01), Coviello et al.
patent: 4214962 (1980-07-01), Pincon
patent: 4336223 (1982-06-01), Hillman
patent: 4384943 (1983-05-01), Stoner et al.
patent: 4400270 (1983-08-01), Hillman
patent: 4458153 (1984-07-01), Wesley
patent: 4471225 (1984-09-01), Hillman
patent: 4494357 (1985-01-01), DiGeronimo
patent: 4524079 (1985-06-01), Hofmann
patent: 4548716 (1985-10-01), Boeve
patent: 4561953 (1985-12-01), Buralidhara et al.
patent: 4656813 (1987-04-01), Baldini et al.
patent: 4719018 (1988-01-01), Przybylski
patent: 4728368 (1988-03-01), Pedziwiatr
patent: 4752401 (1988-06-01), Bodenstein
patent: 4759849 (1988-07-01), Baumann et al.
patent: 4766321 (1988-08-01), Lew et al.
patent: 4808287 (1989-02-01), Hark
patent: 4836929 (1989-06-01), Baumann et al.
patent: 4857204 (1989-08-01), Joklik
patent: 4872959 (1989-10-01), Herbst et al.
patent: 4906387 (1990-03-01), Pisani
patent: 4917782 (1990-04-01), Davies
patent: 4957606 (1990-09-01), Juvan
patent: 4961860 (1990-10-01), Masri
patent: 4963750 (1990-10-01), Wilson
patent: 4990260 (1991-02-01), Pisani
patent: 5026477 (1991-06-01), Yen
patent: 5026564 (1991-06-01), Hayden
patent: 5049400 (1991-09-01), Hayden
patent: 5091152 (1992-02-01), Thomas, Sr.
patent: 5120450 (1992-06-01), Stanley, Jr.
patent: 5130031 (1992-07-01), Johnston
patent: 5130032 (1992-07-01), Sartori
patent: 5198122 (1993-03-01), Koszalka et al.
patent: 5217607 (1993-06-01), Dalton, III et al.
patent: 5240618 (1993-08-01), Caldwell et al.
patent: 5247178 (1993-09-01), Ury et al.
patent: 5259972 (1993-11-01), Miyamaru et al.
patent: 5266215 (1993-11-01), Englehard
patent: 5288412 (1994-02-01), Voorhees et al.
patent: 5290439 (1994-03-01), Buchwald
patent: 5292585 (1994-03-01), Cox
patent: 5304302 (1994-04-01), Bossert
patent: 5326389 (1994-07-01), Cambon
patent: 5368724 (1994-11-01), Ayers et al.
patent: 5376281 (1994-12-01), Safta
patent: 5380445 (1995-01-01), Rivard et al.
patent: 5384032 (1995-01-01), de Souza
patent: 5393417 (1995-02-01), Cox
patent: 5466367 (1995-11-01), Coate et al.
patent: 5466425 (1995-11-01), Adams

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Decontamination system with improved components does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Decontamination system with improved components, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Decontamination system with improved components will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-649232

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.